Shares of Novavax Inc. NVAX, -2.15% slid 2.15% to $19.61 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, +2.05% rising 2.05% to 11,051.64 and the Dow Jones Industrial Average DJIA, +1.88% rising 1.88% to 29,683.74. Novavax Inc. closed $216.89 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Replimune Group Inc. REPL, +3.89% rose 3.89% to $17.34, VBI Vaccines Inc. VBIV, +7.90% rose 7.90% to $0.78, and AnaptysBio Inc. ANAB, +1.71% rose 1.71% to $26.14. Trading volume (4.2 M) remained 1.0 million below its 50-day average volume of 5.2 M.